Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 5 of 98, showing 5 Applications out of 486 total, starting on record 21, ending on 25

# Protocol No Study Title Investigator(s) & Site(s)

21.

ECCT/24/04/07   FORMATIVE-PEARLS TRIAL
    PEARLS FORMATIVE  (Preventing pre-eclampsia: Evaluating AspiRin Low-dose regimens following risk Screening)    
Principal Investigator(s)
1. Zahida Qureshi
2. Alfred Osoti
3. George Gwako
4. Rosa Chemwey
Site(s) in Kenya
1. Kakamega General County Teaching and Referral Hospital (Kakamega county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
3. Kiambu Level 5 Hospital (Kiambu county)
4. Kisii Teaching and Referral Hospital (Kisii county)
5. Meru Teaching and Referral Hospital (Meru county)
 
View

22.

ECCT/24/04/03   SMAART-MAP trial
    Severe Malaria A Research and Trials consortium - Multisite Adaptive Platform trial   
Principal Investigator(s)
1. Prof Kathryn Maitland Maitland
Site(s) in Kenya
Kilifi County Hospital
 
View

23.

ECCT/24/05/03   SIBP-MMR-02
    A Phase III, Multi-Center, Randomized, Observer-Blind, Active Controlled Non-Inferiority Study to Evaluate the Immunogenicity and Safety of Shanghai Institute of Biological Products Co., Ltd.’s Measles, Mumps and Rubella (MMR) Vaccine Compared to a Licensed and WHO Prequalified GSK MMR Vaccine in Healthy African Children, 9- 11 Months of Age   
Principal Investigator(s)
1. Dr Walter Otieno
2. Dr. Diana Odhiambo
Site(s) in Kenya
1. Victoria Biomedical Research Institute (Kisumu county)
2. Victoria Biomedical Research Institute (Kisumu county)
3. Victoria Biomedical Research Institute (Kisumu county)
 
View

24.

ECCT/24/04/02   PEARL RSVt Vaccine Study
    Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL   
Principal Investigator(s)
1. Dr Fredrick Kipyego Sawe
Site(s) in Kenya
1. Walter Reed Army Institute of Research -Kericho Site (Kericho county)
 
View

25.

ECCT/24/06/05   SII-qHPV Vaccine Study
    A Phase-3b, partially double-blind, randomized, multi-country clinical study to evaluate the immunogenicity, safety, and reactogenicity of SIIPL qHPV vaccine (CERVAVAC®) in women living with HIV aged 15-25 years.   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. KEMRI-CCR PHRD Thika (Kiambu county)
2. KEMRI - CCR Nairobi (Nairobi City county)
 
View